Recent Updates
Recently added Catalysts

PDUFA History Tracker

Search historical PDUFA dates and FDA decision outcomes by ticker to understand how specific biotech companies and drug candidates have performed in past regulatory cycles.
Showing 6 Drugs Out Of 332. Click On The Tickers For More Details
Ticker Name PDUFA Date Drug/Therapy Indication Status
ARQT
Arcutis Biotherapeutics, Inc.
2026-06-29
Approved
ARVN
Arvinas, Inc.
2026-06-05
Approved
ARGX
argenx SE
2026-05-10
Approved
AXSM
Axsome Therapeutics, Inc.
2026-04-30
Approved
MRK
Merck & Company, Inc.
2026-04-28
Approved
TVTX
Travere Therapeutics, Inc.
2026-04-13
Approved
API Access

Simple Pricing, Powerful Insights

Full access to Biotech/Pharma investing and trading opportunities.

No hidden fees, powerful insights, tools, and exclusive real time data to maximize your biotech profits.

yearly_arrow
For Visitors

Preview only and discover why serious investors choose our Premium Plan for comprehensive data.

$0.00 / Month

  • Includes 3 day Elite access
For Serious Investor and Traders
Recommended

Your Key to Consistent Profits: Save Big with Our Annual Plan at Just $19.00 per Month

Only $19.00/ Month

  • Searchable FDA Calendar with 1000+ catalysts like clinical readouts and PDUFA
  • Full access to drug pipelines and company health for informed decisions
  • Probability of Approval (PoA) score cards for each asset
  • Download all data in Excel for your models
  • Historical FDA decisions to shape strategic plans
  • Track biotech earnings and critical catalyst events
  • Monitor insider trading and hedge fund holdings for market insights
  • Options flow and strategy modules (screeners and playbooks)
  • Advanced portfolio tools for smart biotech investments
  • Research on 1,100+ companies and clinical trials
  • Real-time market updates, trends, and analysis
  • Live news feed with customizable alerts (tickers, drugs, indications)
  • Exclusive courses on biotech investment basics